You have to be signed in to use this resource.
Propanalol in anxiety
The presentation on propranolol in anxiety treatment highlights safer prescribing practices and the need for increased awareness of its risks. While propranolol is commonly used for situational anxiety (e.g., performance anxiety), it is not a first-line treatment for generalized anxiety disorder (GAD), where psychological therapies (CBT) and medications like SSRIs or SNRIs are preferred. Concerns include the high risk of overdose and limited evidence supporting its effectiveness in anxiety management. Prescribers are advised to limit prescriptions to a maximum two-week supply, conduct regular reviews, educate patients on overdose risks, and cautiously discontinue propranolol if necessary. The session emphasizes staff education, adherence to NICE guidelines, and potential audit work to ensure safer medication use.
Resource details
Contributed by: | Clinical CPD - Primary Care Additional Roles |
Authored by: |
|
Licence: | More information on licences |
Last updated: | 07 July 2025 |
First contributed: | 07 July 2025 |
Audience access level: | General user |
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.